Previous 10 | Next 10 |
home / stock / tlt / tlt articles
Tuesday sees a risk-averse sentiment prevailing in the equity markets, with every sector on Wall Street showing losses as investors await Wednesday...
It’s a quiet start to the week for the U.S. stock market, with investors eagerly anticipating the crucial Federal Reserve interest rate decis...
Risk appetite saw a setback during the final session of the week as stock markets dipped in response to a renewed surge in inflationary pressures. ...
Wall Street edged higher during Wednesday’s midday session, despite the August CPI report showing the annual inflation rate rising to 3.7%, a...
The picture on Wall Street is mixed Tuesday as the broader S&P 500 index experiences a slight dip, primarily due to tech’s lackluster per...
Wall Street started the week on a positive note, with all the major stock averages posting modest yet encouraging gains on Monday. Highlighting the...
Sentiment saw a revival on Friday, but stocks are still on track for a weekly decline. Apple Inc. (NASDAQ:AAPL) rose 1%, putting a halt to the 6% d...
Another session marked by uncertainty was gripping the stock market on Wednesday, following reports that China is contemplating a ban on the use of...
The U.S. stock market resumed trading Tuesday following the Labor Day holiday, and investor confidence appears subdued due to concerns stemming fro...
News, Short Squeeze, Breakout and More Instantly...
iShares 20+ Year Treasury Bond ETF Company Name:
TLT Stock Symbol:
NASDAQ Market:
TORONTO, ON / ACCESSWIRE / July 8, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (" PDCs ...
TORONTO, ON / ACCESSWIRE / June 20, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...